In a study investigating the impact of miR-103a-3p on prostate cancer (PCa) cells, enhancement of miR-103a-3p inhibited migration and invasion of PCa cells by regulating the expression of the oncogenic tumor protein D52 (TPD52) [41]. This evidence concerns the gene TPD52 and prostate carcinoma.